Furthermore, there might be a complex relationship between the serum copper to zinc ratio and TGF-β in patients with bladder cancer, and these two factors might interact with each other within the context of inflammation and oxidative stress in the tumor microenvironment. The gene discussed is TGFB1; the disease is urinary bladder cancer.